Cancer Therapy

You have full text access to this OnlineOpen article

Flaxseed attenuates the tumor growth stimulating effect of soy protein in ovariectomized athymic mice with MCF-7 human breast cancer xenografts

  1. Niina M. Saarinen†,
  2. Krista Power,
  3. Jianmin Chen,
  4. Lilian U. Thompson‡,*

Article first published online: 23 MAR 2006

DOI: 10.1002/ijc.21898

Issue

International Journal of Cancer

International Journal of Cancer

Volume 119, Issue 4, pages 925–931, 15 August 2006

Additional Information

How to Cite

Saarinen, N. M., Power, K., Chen, J. and Thompson, L. U. (2006), Flaxseed attenuates the tumor growth stimulating effect of soy protein in ovariectomized athymic mice with MCF-7 human breast cancer xenografts. Int. J. Cancer, 119: 925–931. doi: 10.1002/ijc.21898

Author Information

  1. Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada

  1. †

    Niina M. Saarinen's current address is: University of Turku, Functional Foods Forum and Institute of Biomedicine, FI-20520 Turku, Finland

  1. ‡

    Fax: +416-978-5882

*Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, 150 College St., Toronto, Ontario, Canada M5S 3E2

Publication History

  1. Issue published online: 1 JUN 2006
  2. Article first published online: 23 MAR 2006
  3. Manuscript Accepted: 12 JAN 2006
  4. Manuscript Received: 5 OCT 2005

Funded by

  • Natural Sciences and Engineering Research Council of Canada. Grant Number: A9995
  • National Technology Agency of Finland. Grant Number: 40285/02

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (208K)

References

  • 1
    Adlercreutz H. Phytoestrogens and breast cancer. J Steroid Biochem Mol Biol 2002; 83: 113–8.
  • 2
    Mazur W, Fotsis T, Wähälä K, Ojala S, Salakka A, Adlercreutz H. Isotope dilution gas chromatographic-mass spectrometric method for the determination of isoflavonoids, coumestrol, and lignans in food samples. Anal Biochem 1996; 233: 169–80.
  • 3
    Axelson M, Sjövall J, Gustafsson BE, Setchell KD. Origin of lignans in mammals and identification of a precursor from plants. Nature 1982; 298: 659–60.
  • 4
    Borriello SP, Setchell KD, Axelson M, Lawson AM. Production and metabolism of lignans by the human faecal flora. J Appl Bacteriol 1985; 58: 37–43.
  • 5
    Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology 1998; 139: 4252–63.
  • 6
    Kinjo J, Tsuchihashi R, Morito K, Hirose T, Aomori T, Nagao T, Okabe H, Nohara T, Masamune Y. Interactions of phytoestrogens with estrogen receptors α and β. III. Estrogenic activities of soy isoflavone aglycones and their metabolites isolated from human urine. Biol Pharmaceut Bull 2004; 27: 185–88.
  • 7
    Mueller SO, Simon S, Chae K, Metzler M, Korach KS. Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor α (ERα) and ERβ in human cells. Toxicol Sci 2004; 80: 14–25.
  • 8
    Saarinen N, Wärri A, Mäkelä SI, Eckerman C, Reunanen M, Ahotupa M, Salmi SM, Franke AA, Kangas L, Santti R. Hydroxymatairesinol, a novel enterolactone precursor with antitumor properties from coniferous tree (Picea abies). Nutr Cancer 2000; 36: 207–16.
  • 9
    Allred CD, Allred KF, Ju YH, Virant SM, Helferich WG. Soy diets containing varying amounts of genistein stimulate growth of estrogen-dependent (MCF-7) tumors in a dose-dependent manner. Cancer Res 2001; 61: 5045–50.
  • 10
    Ju YH, Allred CD, Allred KF, Karko KL, Doerge DR, Helferich WG. Physiological concentrations of dietary genistein dose-dependently stimulate growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in athymic nude mice. J Nutr 2001; 131: 2957–62.
  • 11
    Power KA, Saarinen NM, Chen JM, Thompson LU. Mammalian lignans enterolactone and enterodiol, alone and in combination with the isoflavone genistein, do not promote the growth of MCF-7 xenografts in ovariectomized athymic nude mice. Int J Cancer 2006; 118: 1316–20.
    Direct Link:
  • 12
    Chen J, Hui E, Ip T, Thompson LU. Dietary flaxseed enhances the inhibitory effect of tamoxifen on the growth of estrogen-dependent human breast cancer (mcf-7) in nude mice. Clin Cancer Res 2004; 10: 7703–11.
  • 13
    Serraino M, Thompson LU. The effect of flaxseed supplementation on the initiation and promotional stages of mammary tumorigenesis. Nutr Cancer 1992; 17: 153–9.
  • 14
    Thompson LU, Seidl MM, Rickard SE, Orcheson LJ, Fong HH. Antitumorigenic effect of a mammalian lignan precursor from flaxseed. Nutr Cancer 1996; 26: 159–65.
  • 15
    Saarinen NM, Huovinen R, Wärri A, Mäkelä SI, Valentin-Blasini L, Sjöholm R, Ämmälä J, Lehtilä R, Eckerman C, Collan YU, Santti RS. Enterolactone inhibits the growth of 7,12-dimethylbenz(a)anthracene-induced mammary carcinomas in the rat. Mol Canc Therapeut 2002; 1: 869–76.
  • 16
    Mazur WM, Duke JA, Wähälä K, Rasku S, Adlercreutz H. Isoflavonoids and lignans in legumes: nutritional and health aspects in humans. Nutr Biochem 1998; 9: 193–200.
  • 17
    Nakagawa H, Yamamoto D, Kiyozuka Y, Tsuta K, Uemura Y, Hioki K, Tsutsui Y, Tsubura A. Effects of genistein and synergistic action in combination with eicosapentaenoic acid on the growth of breast cancer cell lines. J Cancer Res Clin Oncol 2000; 126: 448–54.
  • 18
    Reeves PG, Nielsen FH, Fahey GC,Jr. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 1993; 123: 1939–51.
  • 19
    Canadian Council on Animal Care. Guide to the Care and Use of Experimental Animals, vol. 2. Canada: CCAC, 1984.
  • 20
    Rickard SE, Yuan YV, Chen J, Thompson LU. Dose effects of flaxseed and its lignan on N-methyl-N-nitrosourea-induced mammary tumorigenesis in rats. Nutr Cancer 1999; 35: 50–7.
  • 21
    Thompson LU, Chen JM, Li T, Strasser-Weippl K, Goss PE. Dietary flaxseed alters tumor biological markers in postmenopausal breast cancer. Clin Cancer Res 2005; 11: 3828–35.
  • 22
    Allred CD, Allred KF, Ju YH, Goeppinger TS, Doerge DR, Helferich WG. Soy processing influences growth of estrogen-dependent breast cancer tumors. Carcinogenesis 2004; 25: 1649–57.
  • 23
    Chinni SR, Alhasan SA, Multani AS, Pathak S, Sarkar FH. Pleotropic effects of genistein on MCF-7 breast cancer cells. Int J Mol Med 2003; 12: 29–34.
  • 24
    Xiang H, Schevzov G, Gunning P, Williams HM, Silink M. A comparative study of growth-inhibitory effects of isoflavones and their metabolites on human breast and prostate cancer cell lines. Nutr Cancer 2002; 42: 224–32.
  • 25
    Constantinou AI, Lantvit D, Hawthorne M, Xu X, van Breemen RB, Pezzuto JM. Chemopreventive effects of soy protein and purified soy isoflavones on DMBA-induced mammary tumors in female Sprague-Dawley rats. Nutr Cancer 2001; 41: 75–81.
  • 26
    Hakkak R, Korourian S, Shelnutt SR, Lensing S, Ronis MJ, Badger TM. Diets containing whey proteins or soy protein isolate protect against 7,12-dimethylbenz(a)anthracene-induced mammary tumors in female rats. Cancer Epidemiol Biomarkers Prev 2000; 9: 113–7.
  • 27
    Appelt LC, Reicks MM. Soy induces phase II enzymes but does not inhibit dimethylbenz[a]anthracene-induced carcinogenesis in female rats. J Nutr 1999; 129: 1820–6.
  • 28
    Simmen RC, Eason RR, Till SR, Chatman L,Jr, Velarde MC, Geng Y, Korourian S, Badger TM. Inhibition of NMU-induced mammary tumorigenesis by dietary soy. Cancer Lett 2005; 224: 45–52.
  • 29
    Cohen LA, Zhao Z, Pittman B, Scimeca JA. Effect of intact and isoflavone-depleted soy protein on NMU-induced rat mammary tumorigenesis. Carcinogenesis 2000; 21: 929–35.
  • 30
    Ueda M, Niho N, Imai T, Shibutani M, Mitsumori K, Matsui T, Hirose M. Lack of significant effects of genistein on the progression of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in ovariectomized Sprague-Dawley rats. Nutr Cancer 2003; 47: 141–7.
  • 31
    Allred CD, Allred KF, Ju YH, Clausen LM, Doerge DR, Schantz SL, Korol DL, Wallig MA, Helferich WG. Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats. Carcinogenesis 2004; 25: 211–8.
  • 32
    Day JK, Besch-Williford C, McMann TR, Hufford MG, Lubahn DB, MacDonald RS. Dietary genistein increased DMBA-induced mammary adenocarcinoma in wild-type, but not ERα KO, mice. Nutr Cancer 2001; 39: 226–32.
  • 33
    Daun JK, Barthet VJ, Chornick TL, Duguid S. Structure, composition and variety development of flaxseed. In: ThompsonLU, CunnaneSC, eds. Flaxseed in human nutrition, 2nd ed. Illinois: AOAC Press, 2003. 1–40.
  • 34
    Thompson LU, Rickard SE, Orcheson LJ, Seidl MM. Flaxseed and its lignan and oil components reduce mammary tumor growth at a late stage of carcinogenesis. Carcinogenesis 1996; 17: 1373–6.
  • 35
    Wang L, Chen J, Thompson LU. The inhibitory effect of flaxseed on the growth and metastasis of estrogen receptor negative human breast cancer xenografts is attributed to both its lignan and oil components. Int J Cancer 2005; 116: 793–8.
    Direct Link:
  • 36
    Power KA, Thompson LU. Ligand-induced regulation of ERα and ERβ is indicative of human breast cancer cell proliferation. Breast Cancer Res Treat 2003; 81: 209–21.
  • 37
    Murata M, Midorikawa K, Koh M, Umezawa K, Kawanishi S. Genistein and daidzein induce cell proliferation and their metabolites cause oxidative DNA damage in relation to isoflavone-induced cancer of estrogen-sensitive organs. Biochemistry 2004; 43: 2569–77.
  • 38
    Schmidt S, Michna H, Diel P. Combinatory effects of phytoestrogens and 17β-estradiol on proliferation and apoptosis in MCF-7 breast cancer cells. J Steroid Biochem Mol Biol 2005; 94: 445–9.
  • 39
    Welshons WV, Murphy CS, Koch R, Calaf G, Jordan VC. Stimulation of breast cancer cells in vitro by the environmental estrogen enterolactone and the phytoestrogen equol. Breast Cancer Res Treat 1987; 10: 169–75.
  • 40
    Mousavi Y, Adlercreutz H. Enterolactone and estradiol inhibit each other's proliferative effect on MCF-7 breast cancer cells in culture. J Steroid Biochem Mol Biol 1992; 41: 615–9.
  • 41
    Power KA, Ward WE, Chen JM, Saarinen NM, Thompson LU. Genistein alone and in combination with the mammalian lignans, enterolactone and enterodiol, induce estrogenic effects on bone and uterus in a postmenopausal breast cancer mouse model. Bone, [E-pub ahead of press 7 February 2006.]
  • 42
    Adlercreutz H, Bannwart C, Wähälä K, Mäkelä T, Brunow G, Hase T, Arosemena PJ, Kellis JT,Jr, Vickery LE. Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens. J Steroid Biochem Mol Biol 1993; 44: 147–53.
  • 43
    Brooks JD, Thompson LU. Mammalian lignans and genistein decrease the activities of aromatase and 17β-hydroxysteroid dehydrogenase in MCF-7 cells. J Steroid Biochem Mol Biol 2005; 94: 461–7.
  • 44
    Evans BA, Griffiths K, Morton MS. Inhibition of 5α-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids. J Endocrinol 1995; 147: 295–302.
  • 45
    Fotsis T, Pepper M, Adlercreutz H, Hase T, Montesano R, Schweigerer L. Genistein, a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis. J Nutr 1995; 125: 790S–7S.
  • 46
    Youngren JF, Gable K, Penaranda C, Maddux BA, Zavodovskaya M, Lobo M, Campbell M, Kerner J, Goldfine ID. Nordihydroguaiaretic acid (NDGA) inhibits the IGF-1 and c-erbB2/HER2/neu receptors and suppresses growth in breast cancer cells. Breast Cancer Res Treat 2005; 94: 37–46.
  • 47
    Jung HJ, Park HJ, Kim RG, Shin KM, Ha J, Choi JW, Kim HJ, Lee YS, Lee KT. In vivo anti-inflammatory and antinociceptive effects of liriodendrin isolated from the stem bark of Acanthopanax senticosus. Planta Med 2003; 69: 610–6.
  • 48
    Gordaliza M, Castro MA, del Corral JM, Feliciano AS. Antitumor properties of podophyllotoxin and related compounds. Curr Pharm Des 2000; 6: 1811–39.
  • 49
    Yue W, Zhou D, Chen S, Brodie A. A new nude mouse model for postmenopausal breast cancer using MCF-7 cells transfected with the human aromatase gene. Cancer Res 1994; 54: 5092–5.
  • 50
    Gottardis MM, Robinson SP, Jordan VC. Estradiol-stimulated growth of MCF-7 tumors implanted in athymic mice: a model to study the tumoristatic action of tamoxifen. J Steroid Biochem 1988; 30: 311–4.
  • 51
    Jordan VC. Long-term tamoxifen therapy to control or to prevent breast cancer: laboratory concept to clinical trials. Prog Clin Biol Res 1988; 262: 105–23.
  • 52
    Osborne CK, Hobbs K, Clark GM. Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice. Cancer Res 1985; 45: 584–90.
  • 53
    Barnes S. The chemopreventive properties of soy isoflavonoids in animal models of breast cancer. Breast Cancer Res Treat 1997; 46: 169–79.
View Full Article (HTML) Get PDF (208K)